Combination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models. [electronic resource]
Producer: 20100615Description: 503-7 p. digitalISSN:- 1465-3621
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzenesulfonates -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Cell Line, Tumor
- Female
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Lung Neoplasms -- mortality
- Mice
- Mice, Inbred BALB C
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Sorafenib
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.